What drugs does AVERITAS make?

AVERITAS has 2 FDA-approved drugs including MOVANTIK.

What therapeutic areas does AVERITAS focus on?

AVERITAS focuses primarily on Oncology and Neurology.

← Back

Data updated: Mar 29, 2026

AVERITAS

OncologyNeurology

Pharma

AVERITAS is a pharmaceutical company focused on Oncology, Neurology. Key products include MOVANTIK.

2009

Since

Drugs

Trials

Approved (2yr)

Key Drugs

MOVANTIK

naloxegol oxalate

Mu-opioid receptor 2 indications · 2014

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

QUTENZA 2024-07-31

Labeling

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 50%

1 drugs

Neurology 50%

1 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma

Oncology, Neurology

AVERITAS

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info

AVERITAS

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info